| Literature DB >> 27918005 |
Janet Y Li1, Elizabeth Rc Geddes2, Deanne M Robinson3,4, Paul M Friedman1,5,6.
Abstract
Melasma is a pigmentary disorder of unclear etiology with numerous treatment options and high recurrence rates. Laser and light therapies may be utilized cautiously as second- or third-line options for recalcitrant melasma, but low-energy settings are preferred due to the risk of postinflammatory hyperpigmentation and melasma stimulation. Commonly used lasers include the low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser, nonablative fractionated lasers, and intense pulsed light. Strict sun protection, concomitant use of bleaching agents, and maintenance treatments are necessary. A variety of other treatments that may also help to improve results are now being more widely adopted, including oral tranexamic acid, pulsed dye laser, antioxidants, and laser-assisted drug delivery. ©2016 Frontline Medical Communications.Entities:
Keywords: fractional lasers; intense pulsed light; laser; laser-assisted drug delivery; melasma; pulsed dye laser; q-switched; tranexamic acid
Mesh:
Year: 2016 PMID: 27918005 DOI: 10.12788/j.sder.2016.060
Source DB: PubMed Journal: Semin Cutan Med Surg ISSN: 1085-5629